Literatur
Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E (2003) Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVED). J Am Coll Cardiol 42: 705–708
Juurlink DN, Mamdanie MM, Lee DS et al. (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543–551
Pitt B, Remme W, Zannad F (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003: 1309–1321
Pitt B, Zannad F, Remme WJ, Cody R et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–717
Weber KT (2001) Aldosterone in congestive heart failure. N Engl J Med 345: 1689–1697
Wrenger E, Muller R, Moesenthin M, Welte T, Frolich JC, Neumann KH (2003) Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. BMJ 327: 147–149
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Erdmann, E. Effekte der RALE-Studie. Internist 46, 466–468 (2005). https://doi.org/10.1007/s00108-005-1365-1
Issue Date:
DOI: https://doi.org/10.1007/s00108-005-1365-1